Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBTF like 11 (UBTFL11) is classified as a pseudogene and does not code for a functional protein or RNA product[5]. It shares sequence similarity with the upstream binding transcription factor gene (UBTF), but there is no evidence that UBTFL11 acts as a therapeutic target, biological effector, or molecular marker. As a pseudogene, it is not considered in drug development, disease mechanism, or patient selection contexts. Its inclusion as a target would be incorrect for biomedical or pharmacological applications[3][5]. Key interpretation: UBTFL11 is a non-coding pseudogene and not an actionable molecular target. The query may be confusing it with UBTF (Upstream Binding Transcription Factor), which is a genuine transcription factor with clear roles in ribosomal RNA synthesis and disease states[4][6][8][10], but UBTFL11 itself is not therapeutically relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBTF like 11 (pseudogene) (UBTFL11).